Ken Fisher Blueprint Medicines Corp Transaction History

Fisher Asset Management, LLC

$243 Billion
Q3 2024

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Fisher Asset Management, LLC holds 335,350 shares of BPMC stock, worth $29.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

335,350

Previous 336,165 0.24%

Holding current value

$29.2 Million

Previous $36.2 Million 14.42%

% of portfolio

0.01%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$84.1 - $120.5 $68,541 - $98,207	-815 Reduced 0.24%	335,350 $31 Million
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $88,331 - $112,804	1,037 Added 0.31%	336,165 $36.2 Million
Q1 2024 May 09, 2024	BUY	$73.17 - $99.79 $619,310 - $844,622	8,464 Added 2.59%	335,128 $31.8 Million
Q4 2023 Mar 05, 2024	BUY	$43.96 - $92.84 $4,396 - $9,284	100 Added 0.03%	326,664 $30.1 Million
Q4 2023 Feb 06, 2024	SELL	$43.96 - $92.84 $2.43 Million - $5.14 Million	-55,349 Reduced 14.49%	326,564 $30.1 Million
Q3 2023 Nov 13, 2023	SELL	$46.9 - $66.0 $19.6 Million - $27.6 Million	-417,468 Reduced 52.22%	381,913 $19.2 Million
Q2 2023 Dec 12, 2023	BUY	$42.2 - $66.37 $17.6 Million - $27.7 Million	417,468 Added 109.31%	799,381 $50.5 Million
Q2 2023 Aug 08, 2023	SELL	$42.2 - $66.37 $483,865 - $760,998	-11,466 Reduced 1.41%	799,381 $50.5 Million
Q1 2023 Dec 12, 2023	BUY	$37.97 - $50.0 $15.6 Million - $20.6 Million	412,158 Added 107.92%	794,071 $35.7 Million
Q1 2023 May 01, 2023	SELL	$37.97 - $50.0 $1.22 Million - $1.61 Million	-32,243 Reduced 3.82%	810,847 $36.5 Million
Q4 2022 Feb 03, 2023	BUY	$41.06 - $66.48 $4.83 Million - $7.81 Million	117,553 Added 16.2%	843,090 $36.9 Million
Q3 2022 Nov 08, 2022	BUY	$49.93 - $77.7 $7.74 Million - $12 Million	155,026 Added 27.17%	725,537 $47.8 Million
Q2 2022 Aug 09, 2022	BUY	$45.23 - $70.15 $7.8 Million - $12.1 Million	172,456 Added 43.32%	570,511 $28.8 Million
Q1 2022 May 05, 2022	SELL	$54.1 - $110.08 $119,993 - $244,157	-2,218 Reduced 0.55%	398,055 $25.4 Million
Q4 2021 Feb 02, 2022	BUY	$94.25 - $115.99 $7.97 Million - $9.81 Million	84,615 Added 26.81%	400,273 $42.9 Million
Q3 2021 Oct 26, 2021	BUY	$80.98 - $109.47 $25.6 Million - $34.6 Million	315,658 New	315,658 $32.5 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.21B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account